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BAMM 2022 Abstract
Elizabeth Zollinger
St. Joseph’s University, Brooklyn, NY
In this poster we will consider the various mathematical models describing the immune systems
attack on both cancerous tumor cells and cancer stem cells. The stem cell hypothesis suggests that
there is a small group of malignant cells, the cancer stem cells, that initiate the development of tumors, encourage its growth, and may even be the cause of metastases. Traditional treatments, such
as chemotherapy and radiation, primarily target the tumor cells leaving the stem cells to potentially
cause a recurrence. Chimeric antigen receptor (CAR) T-cell therapy is a form of immunotherapy
where the immune cells are genetically modified to fight the tumor cells. Traditionally, the CAR
T-cell therapy has been used to treat blood cancers and only recently has shown promising results
against solid tumors. We create an ordinary differential equations model which allows for the infusion of trained CAR-T cells to specifically attack the cancer stem cells that are present in the solid
tumor microenvironment. Additionally, we incorporate the influence of TGF-β which inhibits the
CAR-T cells and thus promotes the growth of the tumor. We verify the model by comparing it to
available data and then examine combinations of CAR-T cell treatment targeting both non-stem
and stem cancer cells and a treatment that reduces the effectiveness of TGF-β to determine the
scenarios that eliminate the tumor.

